Role of nitric oxide in coronary arterial vasomotion and the influence of coronary atherosclerosis and its risks

American Journal of Cardiology

Volumn 82, Issue 9, 1998, Pages 1034-1039

  Goodhart, David M ^a   Anderson, Todd J ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE;

ADULT; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DOPPLER FLOWMETRY; FEMALE; HEART ATRIUM PACING; HUMAN; INTRACORONARY INFUSION; MALE; PRIORITY JOURNAL; RISK FACTOR; VASOMOTOR REFLEX;

ADULT; CARDIAC PACING, ARTIFICIAL; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; NITRIC OXIDE; OMEGA-N-METHYLARGININE; RISK FACTORS; VASODILATION;

EID: 0031734044     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00550-5     Document Type: Article

References (29)

1. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 1995;38:87-104.
2. Palmer RMJ, Ashton D, Mona S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-666.
3. Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans [see comments]. Circulation 1993;88:43-54.
4. Quyyumi AA, Dakak N, Andrews NP, Hussain S, Arora S, Gilligan DM, Panza JA, Cannon RO III. Nitric oxide activity in the human coronary circulation. J Clin Invest 1995;95:1747-1755.
5. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO III. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation 1995;92:320-326.
6. Shiode N, Nakayama K, Yamagata T, Matsura H, Kajiyama G. Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemia patients. Am Heart J 1996;131:1051-1057.
7. Nishikawa Y, Ogawa S. Importance of nitric oxide in the coronary artery at rest and during pacing in humans. J Am Coll Cardiol 1997;29:85-92.
8. Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold presser test. Circulation 1988;77:43-52.
9. Gordon JB, Ganz P, Nabel EG, Fish RD, Zebede J, Mudge GH, Alexander RW, Selwyn AP. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest 1989;83:1946-1952.
10. Nabel EG, Selwyn AP, Ganz P. Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate [see comments]. Circulation 1990;81:850-859.
11. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-1051.
12. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991;83:391-401.
13. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease [see comments]. Circulation 1990;81:491-497.
14. Seiler C, Hess OM, Buechi M, Suter TM, Krayenbuehl HP. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation 1993;88(part 1):2139-2148.
15. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis [see comments], J Am Coll Cardiol 1990; 16:349-356.
16. Kugiyama K, Yasue H, Ohgushi M, Motoyama T, Kawano H, Inobe Y, Hirashima O, Sugiyama S. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol 1996;28:1161-1167.
17. Rees DD, Palmer RM, Hodson HF, Mona S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium dependent relaxation. Br J Pharmacol 1989;96:418-424.
18. Beresewicz A, Wozniak M. Mechanical performance and coronary flow adjustments to changes in workload are not affected by inhibiting nitric oxide production in isolated working rat heart. Pol J Pharmcacol 1993;45:533-548.
19. Bernstein RD, Ochoa FY, Xu X, Forfia P, Shen W, Thompson CI, Hintze TH. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circulation 1996;79:840-848.
20. Ishibashi Y, Duncker DJ, Bache RJ. Endogenous nitric oxide masks alpha2-adrenergic coronary vasoconstriction during exercise in the ischemic heart. Circ Res 1997;80:196-207.
21. Feletou M, Vanhoute PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988;93:515-524.
22. Duncker DJ, Van Zon NS, Ishibashi Y, Bache RJ. Role of K+CADATP channels and adenosine in the regulation of coronary blood flow during exercise with normal and restricted coronary blood flow. J Clin Invest 1996;97:996-1009.
23. Vanhoutte PM. Other endothelium-derived vasoactive factors. Circulation 1993;87(suppl V):V-9-V-17.
24. Komaru T, Tanikawa T, Sugimora A, Kumagai T, Sato K, Kanatsuka H, Shirato K. Mechanism of coronary microvascular dilation induced by the activation of pertussis toxin-sensitive G proteins are vessel size dependent. Circ Res 1997;80:1-10.
25. Tousoulis D, Tentolouris C, Crake T, Toutouzas P, Davies G. Basal and flow-mediated nitric oxide production by atheromatous coronary arteries. J Am Coll Cardiol 1997;29:1256-1262.
26. Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Kubota T, Hirakawa Y, Takeshita A. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. Circ Res 1996;79:333-335.
27. Hodgson JM, Marshall JJ. Direct vasoconstriction and endothelium dependent vasodilation: mechanisms of acetylcholine effects on coronary arterial flow and diameter in patients with nonstenotic coronary arteries. Circulation 1989;79: 1043-1051.
28. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Luscher TE. Nitric oxide is responsible for flow-mediated dilation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314-1319.
29. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T. Clinical implications of the "no reflow" phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-228.